{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:56:35Z","timestamp":1791820595739,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Carnitine uptake deficiency (CUD) is an inherited disorder caused by\n                      <jats:italic>SLC22A5<\/jats:italic>\n                      gene variants resulting in low plasma and intracellular carnitine concentrations. Although newborn screening (NBS) enables a timely diagnosis of CUD, its efficiency is being debated. The aim of this work was to assess the benefits and limitations of NBS for CUD. A retrospective, observational single-center study was conducted on newborns born between 2017 and 2020 recalled for low free carnitine (C0) values. Biochemical, molecular, dietary and perinatal data were collected. Maternal acylcarnitine profiles and\n                      <jats:italic>SLC22A5<\/jats:italic>\n                      genotype were also recorded, if available.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 160,015 newborns in the study period, forty-six infants were enrolled in the study: three infants were diagnosed with CUD (incidence 1:53,338 newborns), sixteen infants with a maternal disorder, five infants with one heterozygous\n                      <jats:italic>SLC22A5<\/jats:italic>\n                      variant, and nineteen (41%) infants were false positives. Among false positives, additional factors potentially contributing to the observed low C0 values (i.e., gestational age\u2009&lt;\u200937 weeks, low birth weight, C-section, exclusive breastfeeding) were identified. All enrolled infants were asymptomatic. The association of low C0 with concurrent C\n                      <jats:sub>tot<\/jats:sub>\n                      values\u2009\u2264\u200919 \u00b5mol\/L in dried blood spot appeared to argue against a false positive case.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collected data showed that NBS for CUD is burdened by a high false positive rate. Besides individuals with CUD, those with maternal disorders and heterozygous individuals who do not require medical care were also identified. Increasing the efficiency of NBS is a compelling need. Possible strategies to minimize false positives include regular revision of diagnostic cutoffs assessment of fractional excretion of carnitine and implementation of new analytical strategies such as the development of second-tier tests.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04133-0","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T02:29:26Z","timestamp":1764296966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benefits and pitfalls in newborn screening for carnitine uptake deficiency: a 4-year single-center experience"],"prefix":"10.1186","volume":"21","author":[{"given":"Mariagrazia","family":"Turturo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1689-4948","authenticated-orcid":false,"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Barretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Crisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Uomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fecarotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Alagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Frisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"4133_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/molecules25010014","volume":"25","author":"B Juraszek","year":"2019","unstructured":"Juraszek B, Na\u0142\u0119cz KA. SLC22A5 (OCTN2) carnitine Transporter-Indispensable for cell Metabolism, a Jekyll and Hyde of human cancer. Molecules. 2019;25(1):14. https:\/\/doi.org\/10.3390\/molecules25010014.","journal-title":"Molecules"},{"issue":"18","key":"4133_CR2","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.3390\/molecules24183251","volume":"24","author":"M Almannai","year":"2019","unstructured":"Almannai M, Alfadhel M, El-Hattab AW. Carnitine inborn errors of metabolism. Molecules. 2019;24(18):3251. https:\/\/doi.org\/10.3390\/molecules24183251.","journal-title":"Molecules"},{"issue":"8","key":"4133_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/088800101753328457","volume":"18","author":"AP Cemeroglu","year":"2001","unstructured":"Cemeroglu AP, Kocaba\u015f CN, Co\u015fkun T, G\u00fcrgey A. Low serum carnitine concentrations in healthy children with iron deficiency anemia. Pediatr Hematol Oncol. 2001;18(8):491\u20135. https:\/\/doi.org\/10.1080\/088800101753328457.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"4133_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10545-012-9488-8","volume":"36","author":"J Rasmussen","year":"2013","unstructured":"Rasmussen J, Nielsen OW, Lund AM, K\u00f8ber L, Djurhuus H. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J Inherit Metab Dis. 2013;36(1):35\u201341. https:\/\/doi.org\/10.1007\/s10545-012-9488-8.","journal-title":"J Inherit Metab Dis"},{"key":"4133_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1023\/A:1025968502527","volume":"26","author":"U Spiekerkoetter","year":"2003","unstructured":"Spiekerkoetter U, Huener G, Baykal T, Demirkol M, Duran M, Wanders R, Nezu J, Mayatepek E. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation\/carnitine transporter OCTN2. J Inherit Metab Dis. 2003;26:613\u20135. https:\/\/doi.org\/10.1023\/A:1025968502527.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"4133_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10545-006-0376-y","volume":"29","author":"S Vijay","year":"2006","unstructured":"Vijay S, Patterson A, Olpin S, Henderson MJ, Clark S, Day C, Savill G, Walter JH. Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis. 2006;29(5):627\u201330. https:\/\/doi.org\/10.1007\/s10545-006-0376-y.","journal-title":"J Inherit Metab Dis"},{"key":"4133_CR7","unstructured":"El-Hattab AW, et al. Systemic primary carnitine deficiency. In: Adam MP, Everman DB, Mirzaa GM, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132023."},{"issue":"2","key":"4133_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.clp.2015.03.002","volume":"42","author":"SA Berry","year":"2015","unstructured":"Berry SA. \u2013\u200953, x. Newborn Screen Clin Perinatol. 2015;42(2):441\u2013. https:\/\/doi.org\/10.1016\/j.clp.2015.03.002.","journal-title":"Newborn Screen Clin Perinatol"},{"key":"4133_CR9","doi-asserted-by":"publisher","first-page":"100632","DOI":"10.1016\/j.ymgmr.2020.100632","volume":"24","author":"A Magnuolo","year":"2020","unstructured":"Magnuolo A, Rodella G, Dianin A, Nurti R, Monge I, Rigotti E, Cantalupo G, Salviati L, Tucci S, Pellegrini F, Molinaro G, Lupi F, Tonin P, Pasini A, Campostrini N, Ion Popa F, Teofoli F, Vincenzi M, Camiloti M, Piacentini G, Bordugo A. Diagnosis, genetic characterization and clinical follow-up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience. Mol Genet Metab Rep. 2020;24:100632. https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100632.","journal-title":"Mol Genet Metab Rep"},{"key":"4133_CR10","first-page":"100632","volume":"24","author":"KA Schiergens","year":"2020","unstructured":"Schiergens KA, Weiss KJ, Roschinger W, Lotz-Havla AS, Schmitt J, Dalla Pozza R, Ulrich S, Odenwald B, Kreuder J, Maier EM. Newborn screening for carnitine transporter defect in Bavaria and the long-term follow-up of the identified newborns and mothers: assessing the benefit and possible harm based on 19 \u00bd years of experience. Mol Genet Metabolism Rep. 2020;24:100632.","journal-title":"Mol Genet Metabolism Rep"},{"issue":"3","key":"4133_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ymgme.2017.06.015","volume":"122","author":"NM Gallant","year":"2017","unstructured":"Gallant NM, Leydiker K, Wilnai Y, Lee C, Lorey F, Feuchtbaum L, Tang H, Carter J, Enns GM, Packman S, Lin HJ, Wilcox ER, Cederbaum SD, Abdenur JE. Biochemical characteristics of newborns with carnitine transporter defect identified by newborn screening in California. Mol Genet Metab. 2017;122(3):76\u201384. https:\/\/doi.org\/10.1016\/j.ymgme.2017.06.015.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4133_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jimd.12030","volume":"42","author":"C Wilson","year":"2019","unstructured":"Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. The decision to discontinue screening for carnitine uptake disorder in new Zealand. J Inherit Metab Dis. 2019;42(1):86\u201392. https:\/\/doi.org\/10.1002\/jimd.12030.","journal-title":"J Inherit Metab Dis"},{"key":"4133_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/jimd.12386","volume":"44","author":"A Rossi","year":"2021","unstructured":"Rossi A, Hoogeveen IJ, Lubout CMA, de Boer F, Fokkert-Wilts MJ, Rodenburg IL, van Dam E, Gr\u00fcnert SC, Martinelli D, Scarpa M, CONNECT MetabERN Collaboration Group, Dekker H, te Boekhorst ST, van Spronsen FJ, Derks TGJ. A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net. Inherit Metab Dis. 2021;44:1124\u201335.","journal-title":"Inherit Metab Dis"},{"key":"4133_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41390-019-0497-2","volume":"86","author":"F Baronio","year":"2019","unstructured":"Baronio F, Righi B, Righetti F, Bettocchi I, Ortolano R, Faldella G, Rondelli R, Pession A, Cassio A. Carnitine longitudinal pattern in preterm infants\u2009<\u20091800\u00a0g body weight: a case\u2013control study. Pediatr Res. 2019;86:646\u201350.","journal-title":"Pediatr Res"},{"key":"4133_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/MPG.0b013e31829fad06","volume":"57","author":"J Bene","year":"2013","unstructured":"Bene J, et al. Differences in Circulating carnitine status of preterm infants fed fortified human milk or preterm infant formula. J Pediatr Gastroenterol Nutr. 2013;57:673\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"4133_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1039\/c4mb00729h","volume":"11","author":"E Scolamiero","year":"2015","unstructured":"Scolamiero E, Cozzolino C, Albano L, Ansalone A, Caterino M, Corbo G, di Girolamo MG, Di Stefano C, Durante A, Franzese G, Franzese I, Gallo G, Giliberti P, Ingenito L, Ippolito G, Malamisura B, Mazzeo P, Norma A, Ombrone D, Parenti GC, Pellecchia S, Pecce R, Pierucci I, Romanelli R, Rossi A, Siano M, Stoduto T, Villa G, Andria G, Salvatore F, Frisso G, Ruoppolo M. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. Mol Biosyst. 2015;11(6):1525\u201335. https:\/\/doi.org\/10.1039\/c4mb00729h.","journal-title":"Mol Biosyst"},{"issue":"7","key":"4133_CR17","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1002\/mgg3.1260","volume":"8","author":"B Lombardo","year":"2020","unstructured":"Lombardo B, D\u2019Argenio V, Monda E, Vitale A, Caiazza M, Sacchetti L, Pastore L, Limongelli G, Frisso G, Mazzaccara C. Genetic analysis resolves differential diagnosis of a Familial syndromic dilated cardiomyopathy: A new case of Alstr\u00f6m syndrome. Mol Genet Genomic Med. 2020;8(7):e1260. https:\/\/doi.org\/10.1002\/mgg3.1260.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"4133_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"12","key":"4133_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, O\u2019Donnell-Luria A, Harrison SM, Tavtigian SV, Greenblatt MS, Biesecker LG, Radivojac P, Brenner SE, ClinGen Sequence Variant Interpretation Working Group. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022;109(12):2163\u201377. https:\/\/doi.org\/10.1016\/j.ajhg.2022.10.013.","journal-title":"Am J Hum Genet"},{"key":"4133_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cca.2020.04.039","volume":"507","author":"Y Lin","year":"2020","unstructured":"Lin Y, Xu H, Zhou D, Hua Z, Zhang C, Zhou W, Zhang L, Huang T, Li W. Screening 3.4 million newborns for primary carnitine deficiency in Zhejiang Province, China. Clin Chim Acta. 2020;507:199\u2013204.","journal-title":"Clin Chim Acta"},{"key":"4133_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cca.2020.11.005","volume":"512","author":"W Lin","year":"2021","unstructured":"Lin W, Wang K, Zheng Z, Chen Y, Fu C, Lin Y, Chen D. Newborn screening for primary carnitine deficiency in Quanzhou, China. Clin Chim Acta. 2021;512:166\u201371.","journal-title":"Clin Chim Acta"},{"key":"4133_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jimd.12475","volume":"45","author":"LL Crefcoeur","year":"2022","unstructured":"Crefcoeur LL, Visser G, Ferdinandusse S, Wijburg FA, Langeveld M, Sjouke B. Clinical characteristics of primary carnitine deficiency: A structured review using a case-by-case approach. J Inherit Metab Dis. 2022;45:386\u2013405.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"4133_CR23","doi-asserted-by":"publisher","first-page":"e15404","DOI":"10.1111\/ped.15404","volume":"65","author":"S Liammongkolkul","year":"2023","unstructured":"Liammongkolkul S, Boonyawat B, Vijiarnsorn C, Tim-Aroon T, Wasant P, Vatanavicharn N. Phenotypic and molecular features of Thai patients with primary carnitine deficiency. Pediatr Int. 2023;65(1):e15404.","journal-title":"Pediatr Int"},{"key":"4133_CR24","doi-asserted-by":"crossref","unstructured":"Lin W, Wang K, Zheng Z, Chen Y, Fu C, Lin Y, Chen D, Rasmussen J, Lund AM, Risom L, Wibrand F, Gislason H, Nielsen OW, K\u00f8ber L, Duno M. Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency. Mol Genet Metab. 2014;241\u20138.","DOI":"10.1016\/j.ymgmr.2014.04.008"},{"key":"4133_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/ijns8030047","volume":"8","author":"M Ruoppolo","year":"2022","unstructured":"Ruoppolo M, et al. Expanded newborn screening in Italy using tandem mass spectrometry: two years of National experience. Int J Neonatal Screen. 2022;8:47. https:\/\/doi.org\/10.3390\/ijns8030047.","journal-title":"Int J Neonatal Screen"},{"issue":"12","key":"4133_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/humu.23315","volume":"38","author":"M Frigeni","year":"2017","unstructured":"Frigeni M, Balakrishnan B, Yin X, Calderon FRO, Mao R, Pasquali M, Longo N. Functional and molecular studies in primary carnitine deficiency. Hum Mutat. 2017;38(12):1684\u201399. https:\/\/doi.org\/10.1002\/humu.23315.","journal-title":"Hum Mutat"},{"issue":"46","key":"4133_CR27","doi-asserted-by":"publisher","first-page":"e2210247119","DOI":"10.1073\/pnas.2210247119","volume":"119","author":"ML Koleske","year":"2022","unstructured":"Koleske ML, McInnes G, Brown JEH, Thomas N, Hutchinson K, Chin MY, Koehl A, Arkin MR, Schlessinger A, Gallagher RC, Song YS, Altman RB, Giacomini KM. Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for carnitine transporter deficiency. Proc Natl Acad Sci U S A. 2022;119(46):e2210247119. https:\/\/doi.org\/10.1073\/pnas.2210247119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4133_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jmg-2023-109206","volume":"0","author":"L Crefcoeur","year":"2023","unstructured":"Crefcoeur L, Ferdinandusse S, van der Crabben SN, Dekkers E, Fuchs SA, Huidekoper H, Janssen M, Langendonk JL, Maase R, de Sain M, Rubio E, van Spronsen FJ, Vaz FM, Verschoof R, de Vries M, Wijburg F, Visser G, Langeveld M. Newborn screening for primary carnitine deficiency: who will benefit? A retrospective cohort study. J Med Genet. 2023;0:1\u20139. https:\/\/doi.org\/10.1136\/jmg-2023-109206.","journal-title":"J Med Genet"},{"issue":"6","key":"4133_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/ejhg.2015.198","volume":"24","author":"CL Hertz","year":"2016","unstructured":"Hertz CL, Christiansen SL, Larsen MK, Dahl M, Ferrero-Miliani L, Weeke PE, Pedersen O, Hansen T, Grarup N, Ottesen GL, Frank-Hansen R, Banner J, Morling N. Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases. Eur J Hum Genet. 2016;24(6):817\u201322. https:\/\/doi.org\/10.1038\/ejhg.2015.198.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4133_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ejhg.2016.199","volume":"25","author":"J Neubauer","year":"2017","unstructured":"Neubauer J, Lecca MR, Russo G, Bartsch C, Medeiros-Domingo A, Berger W, Haas C. Post-mortem whole-exome analysis in a large sudden infant death syndrome cohort with a focus on cardiovascular and metabolic genetic diseases. Eur J Hum Genet. 2017;25(4):404\u20139. https:\/\/doi.org\/10.1038\/ejhg.2016.199.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"4133_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/genes12081262","volume":"12","author":"S Barbosa-Gouveia","year":"2021","unstructured":"Barbosa-Gouveia S, V\u00e1zquez-Mosquera ME, Gonz\u00e1lez-Vioque E, \u00c1lvarez JV, Chans R, Laranjeira F, Martins E, Ferreira AC, Avila-Alvarez A, Couce ML. Utility of gene panels for the diagnosis of inborn errors of metabolism in a metabolic reference center. Genes (Basel). 2021;12(8):1262. https:\/\/doi.org\/10.3390\/genes12081262.","journal-title":"Genes (Basel)"},{"key":"4133_CR32","doi-asserted-by":"publisher","unstructured":"Jakoby M 4th, Jaju A, Marsh A, Wilber A. Maternal primary carnitine deficiency and a novel solute carrier family 22 member 5 (SLC22A5) mutation. J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211019543. https:\/\/doi.org\/10.1177\/23247096211019543.","DOI":"10.1177\/23247096211019543"},{"issue":"8","key":"4133_CR33","doi-asserted-by":"publisher","first-page":"E1632","DOI":"10.1002\/humu.21311","volume":"31","author":"F-Y Li","year":"2010","unstructured":"Li F-Y, El-Hattab AW, Bawle EV, Boles RG, Schmitt ES, Scaglia F, Wong LJ. Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency. Hum Mutat. 2010;31(8):E1632\u201351. https:\/\/doi.org\/10.1002\/humu.21311.","journal-title":"Hum Mutat"},{"key":"4133_CR34","doi-asserted-by":"publisher","first-page":"1304458","DOI":"10.3389\/fgene.2023.1304458","volume":"14","author":"X Ji","year":"2023","unstructured":"Ji X, Ge Y, Ni Q, Xu S, Xiong Z, Yang L, Hu L, Cao Y, Lu Y, Wei Q, Kang W, Zhuang D, Zhou W, Dong X. Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening. Front Genet. 2023;14:1304458. https:\/\/doi.org\/10.3389\/fgene.2023.1304458.","journal-title":"Front Genet"},{"issue":"3","key":"4133_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2019.12.006","volume":"129","author":"KC Verbeeten","year":"2020","unstructured":"Verbeeten KC, Lam-honwah AM, Bulman D, Faghfoury H, Chakraborty P, Tein I, Geraghty MT. Carnitine uptake defect due to a 5\u2019UTR mutation in a pedigree with false positives and false negatives on newborn screening. Mol Genet Metab. 2020;129(3):213\u20138.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"4133_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ymgme.2008.01.005","volume":"94","author":"EA Crombez","year":"2008","unstructured":"Crombez EA, Cederbaum SD, Spector ES, Chan E, Salazar D, Neidich J, Goodman S. Maternal glutaric Acidemia, type I identified by newborn screening. Mol Genet Metab. 2008;94(1):132\u20134.","journal-title":"Mol Genet Metab"},{"key":"4133_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1399-0004.2009.01368.x","volume":"78","author":"K Sarafoglou","year":"2010","unstructured":"Sarafoglou K, Tridgell AHC, Bentler K, Redlinger-Grosse K, Berry SA, Schimmenti LA. Cardiac conduction improvement in two heterozygotes for primary carnitine deficiency on l-carnitine supplementation. Clin Genet. 2010;78:191\u20134.","journal-title":"Clin Genet"},{"issue":"9","key":"4133_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12098-013-0980-4","volume":"80","author":"I Mandour","year":"2013","unstructured":"Mandour I, et al. Amino acid and acylcarnitine profiles in premature neonates: a pilot study. Indian J Pediatr. 2013;80(9):736\u201344. https:\/\/doi.org\/10.1007\/s12098-013-0980-4.","journal-title":"Indian J Pediatr"},{"issue":"4","key":"4133_CR39","first-page":"657","volume":"40","author":"CR Lef\u00e8vre","year":"2004","unstructured":"Lef\u00e8vre CR, Labarthe F, Philippe G, Harambat J, Parvy P, Dore L, Tordjman M, Chabrol B, Gagnadoux MF. Liver transplant for primary carnitine deficiency. J Hepatol. 2004;40(4):657\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"4133_CR40","first-page":"168","volume":"42","author":"A Salguero Olid","year":"2018","unstructured":"Salguero Olid A, Blanco S\u00e1nchez G, Alonso Ojembarrena A. A systematic review about prophylactic L-carnitine administration in parenteral nutrition of extremely preterm infants. Farm Hosp. 2018;42(4):168\u201373.","journal-title":"Farm Hosp"},{"key":"4133_CR41","doi-asserted-by":"publisher","first-page":"17562","DOI":"10.1038\/s41598-019-53810-1","volume":"9","author":"L Marchioro","year":"2019","unstructured":"Marchioro L, Shokry E, Geraghty AA, O\u2019Brien EC, Uhl O, Koletzko B, McAulife FM. Caesarean section, but not induction of labour, is associated with major changes in cord blood metabolome. Sci Rep. 2019;9:17562.","journal-title":"Sci Rep"},{"key":"4133_CR42","first-page":"57","volume":"64","author":"LL Crefcoeur","year":"2023","unstructured":"Crefcoeur LL, Heiner-Fokkema MR, Maase RE, Visser G, de Sain-van der Velden MG. Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns. JIMD Rep. 2023;64:57\u201364.","journal-title":"JIMD Rep"},{"key":"4133_CR43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13023-021-02126-3","volume":"16","author":"Y Lin","year":"2021","unstructured":"Lin Y, Lin B, Chen Y, Zheng Z, Fu Q, Lin W, Zhang W. Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening. Orphanet J Rare Dis. 2021;16:503.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"4133_CR44","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","volume":"26","author":"AN Adhikari","year":"2020","unstructured":"Adhikari AN, Gallagher RC, Wang Y, Currier RJ, Amatuni G, Bassaganyas L, Chen F, Kundu K, Kvale M, Mooney SD, Nussbaum RL, Randi SS, Sanford J, Shieh JT, Srinivasan R, Sunderam U, Vaka D, Zou Y, Koenig BA, Kwok PY, Risch N, Puck JM, Brenner SE. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392\u20137. https:\/\/doi.org\/10.1038\/s41591-020-0966-5.","journal-title":"Nat Med"},{"issue":"2","key":"4133_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajhg.2022.08.003","volume":"111","author":"SF Kingsmore","year":"2022","unstructured":"Kingsmore SF, Smith LD, Kunard CM, Willis MJ, Wolen AR, Defay T. A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. AJHG. 2022;111(2):135\u201345. https:\/\/doi.org\/10.1016\/j.ajhg.2022.08.003.","journal-title":"AJHG"},{"issue":"7","key":"4133_CR46","first-page":"809","volume":"30","author":"Y Sun","year":"2017","unstructured":"Sun Y, Wang Y, Jiang T. Clinical features and genotyping of patients with primary carnitine deficiency identified by newborn screening. J Pediatr Endocrinol Metab. 2017;30(7):809\u201315.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"4133_CR47","first-page":"45","volume":"6","author":"S Malvagia","year":"2020","unstructured":"Malvagia S, Forni G, Ombrone D, la Marca G. Development of strategies to decrease false positive results in newborn screening. Int J Neonatal Screen. 2020;6(1):45.","journal-title":"Int J Neonatal Screen"},{"key":"4133_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2350-14-24","volume":"14","author":"LY Wang","year":"2013","unstructured":"Wang LY, Chen NI, Chen PW, Chiang SC, Hwu WL, Lee NC, Chien YH. Newborn screening for Citrin deficiency and carnitine uptake defect using second-tier molecular tests. BMC Med Genet. 2013;14:24. https:\/\/doi.org\/10.1186\/1471-2350-14-24.","journal-title":"BMC Med Genet"},{"issue":"1","key":"4133_CR49","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13023-023-02735-0","volume":"18","author":"LM van den Heuvel","year":"2023","unstructured":"van den Heuvel LM, Kater-Kuipers A, van Dijk T, Crefcoeur L, Visser G, Langeveld M, Henneman L. A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child. Orphanet J Rare Dis. 2023;18(1):134. https:\/\/doi.org\/10.1186\/s13023-023-02735-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4133_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13023-024-03267-x","volume":"19","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li G, Zeng Y, Qiu X, Zhao P, Huang T, Wang X, Luo J, Lin N, Xu L. Screening primary carnitine deficiency in 10 million Chinese newborns: a systematic review and meta-analysis. Orphanet J Rare Dis. 2024;19(1):248. https:\/\/doi.org\/10.1186\/s13023-024-03267-x.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4133_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1515\/jpem-2023-0513","volume":"37","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lin C, Zheng Z, Huang C, Peng W. Newborn screening for primary carnitine deficiency using a second-tier genetic test. J Pediatr Endocrinol Metab. 2024;37(2):163\u20139. https:\/\/doi.org\/10.1515\/jpem-2023-0513.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"4133_CR52","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1002\/mgg3.70003","volume":"12","author":"Y Lin","year":"2024","unstructured":"Lin Y, Zheng Z, Lin W, Peng W. Incorporating Next-Generation sequencing as a Second-Tier test for primary carnitine deficiency. Mol Genet Genomic Med. 2024;12(9):e70003. https:\/\/doi.org\/10.1002\/mgg3.70003.","journal-title":"Mol Genet Genomic Med"},{"issue":"6","key":"4133_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jmd2.12383","volume":"64","author":"RK Abrahamsen","year":"2023","unstructured":"Abrahamsen RK, Lund AM, Rasmussen J. Patients with primary carnitine deficiency treated with L-carnitine are alive and doing well: A 10-year follow-up in the Faroe Islands. JIMD Rep. 2023;64(6):453\u20139. https:\/\/doi.org\/10.1002\/jmd2.12383.","journal-title":"JIMD Rep"},{"issue":"1","key":"4133_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13052-025-01911-1","volume":"51","author":"H Hu","year":"2025","unstructured":"Hu H, Ma Q, Wang Y, Song W, Xu H. Newborn screening of primary carnitine deficiency: clinical and molecular genetic characteristics. Ital J Pediatr. 2025;51(1):70. https:\/\/doi.org\/10.1186\/s13052-025-01911-1.","journal-title":"Ital J Pediatr"},{"key":"4133_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-021-01785-6","volume":"16","author":"Y Lin","year":"2021","unstructured":"Lin Y, Zhang W, Huang C, Lin C, Lin W, Peng W, Fu Q, Chen D. Increased detection of primary carnitine deficiency through second-tier newborn genetic screening. Orphanet J Rare Dis. 2021;16:149.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04133-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:01:58Z","timestamp":1781618518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04133-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4133"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04133-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Medical Ethical Committee of the University of Naples \u201cFederico II\u201d. Written informed consent from the participants\u2019 legal guardian\/parent was not required to participate in this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}